Effect of clarithromycin add-on therapy for patients with lenalidomid-resistant multiple myeloma

MLA

Shogo Miura, et al. “Effect of Clarithromycin Add-on Therapy for Patients with Lenalidomid-Resistant Multiple Myeloma.” Annals of Oncology, vol. 27, Nov. 2016, pp. vii86-vii87. EBSCOhost, https://doi.org/10.1093/annonc/mdw521.052.

APA

Shogo Miura, Naoki Uemura, Masahiro Maeda, Hiroto Horiguchi, Tomoyuki Abe, Junji Kato, Takanori Shibata, Ken Sato, Shigeyuki Fujii, Hiroyuki Kuroda, & Michiko Yamada. (2016). Effect of clarithromycin add-on therapy for patients with lenalidomid-resistant multiple myeloma. Annals of Oncology, 27, vii86-vii87. https://doi.org/10.1093/annonc/mdw521.052

Chicago

Shogo Miura, Naoki Uemura, Masahiro Maeda, Hiroto Horiguchi, Tomoyuki Abe, Junji Kato, Takanori Shibata, et al. 2016. “Effect of Clarithromycin Add-on Therapy for Patients with Lenalidomid-Resistant Multiple Myeloma.” Annals of Oncology 27 (November): vii86-vii87. doi:10.1093/annonc/mdw521.052.